(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Part 1 covers topics such as disease activities, treatment methods and the therapeutic effects of biological agents in JIA. Part 2 presents the results of case by case investigations of events seen in Japanese clinical trials of tocilizumab and the way they were handled. A summary of the case reports, including the study methods and results is also included. The book covers various treatment reactions, including adverse drug reactions, which occur when protein drugs are administered in human patients.
Contents:
Part 1 Introduction
Part 1 Overview
Part 2 Summary of Studies
Case Reports
1. Good Cases
2. Infection Cases
3. Hepatitis Cases
4. Anaphylactic Cases
5. MAS Cases
6. GI Bleeding Cases
7. Surgery Cases
8. Others
Editor and Author Contact Information
PRODUCT DETAILS
Publisher: Springer (Springer Healthcare)
Publication date: July, 2012
Pages: 180
Dimensions: 182.00 x 257.00 x 8.00
Weight: 1000g
Availability: Not available (reason unspecified)
Subcategories: Rheumatology